首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1090064篇
  免费   74382篇
  国内免费   1430篇
耳鼻咽喉   15146篇
儿科学   34972篇
妇产科学   28907篇
基础医学   155659篇
口腔科学   29875篇
临床医学   96551篇
内科学   207027篇
皮肤病学   24581篇
神经病学   83213篇
特种医学   43585篇
外国民族医学   201篇
外科学   165573篇
综合类   21994篇
现状与发展   1篇
一般理论   281篇
预防医学   76172篇
眼科学   24874篇
药学   87330篇
  8篇
中国医学   2847篇
肿瘤学   67079篇
  2019年   8048篇
  2018年   11588篇
  2017年   9145篇
  2016年   10345篇
  2015年   11605篇
  2014年   15716篇
  2013年   22932篇
  2012年   31603篇
  2011年   33351篇
  2010年   19566篇
  2009年   18399篇
  2008年   30930篇
  2007年   33216篇
  2006年   33865篇
  2005年   32226篇
  2004年   30799篇
  2003年   29599篇
  2002年   28567篇
  2001年   60229篇
  2000年   61659篇
  1999年   51155篇
  1998年   12654篇
  1997年   11214篇
  1996年   11176篇
  1995年   10477篇
  1994年   9498篇
  1993年   9016篇
  1992年   37917篇
  1991年   36385篇
  1990年   35861篇
  1989年   34412篇
  1988年   31011篇
  1987年   30095篇
  1986年   28347篇
  1985年   26569篇
  1984年   19328篇
  1983年   16267篇
  1982年   8965篇
  1979年   17108篇
  1978年   11481篇
  1977年   10316篇
  1976年   8897篇
  1975年   10124篇
  1974年   11721篇
  1973年   11322篇
  1972年   10787篇
  1971年   10125篇
  1970年   9280篇
  1969年   8958篇
  1968年   7937篇
排序方式: 共有10000条查询结果,搜索用时 511 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.

Physical activity brings significant health benefits to middle-aged adults, although the research to date has been focused on late adulthood. This study aims to examine how ageing affects the self-reported and accelerometer-derived measures of physical activity levels in middle-aged adults. We employed the data recorded in the UK Biobank and analysed the physical activity levels of 2,998 participants (1381 men and 1617 women), based on self-completion questionnaire and accelerometry measurement of physical activity. We also assessed the musculoskeletal health of the participants using the dual-energy X-ray absorptiometry (DXA) measurements provided by the UK Biobank. Participants were categorised into three groups according to their age: group I younger middle-aged (40 to 49 years), group II older middle-aged (50 to 59 years), and group III oldest middle-aged (60 to 69 years). Self-reported physical activity level increased with age and was the highest in group III, followed by group II and I (P?<?0.05). On the contrary, physical activity measured by accelerometry decreased significantly with age from group I to III (P?<?0.05), and the same pertained to the measurements of musculoskeletal health (P?<?0.05). It was also shown that middle-aged adults mostly engaged in low and moderate intensity activities. The opposing trends of the self-reported and measured physical activity levels may suggest that middle-aged adults over-report their activity level as they age. They should be aware of the difference between their perceived and actual physical activity levels, and objective measures would be useful to prevent the decline in musculoskeletal health.

  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号